There has been a rapid emergence of numerous targeted agents in the oncology community
in the last decade. This exciting paradigm shift in drug development lends promise for the …

The development of paediatric medicines can be challenging since this is a diverse patient
population with specific needs. For example, the toxicity of excipients may differ in children …

The last decade has spawned an exciting new era of oncotherapy in dermatology, including
the development of targeted therapies for metastatic melanoma and basal cell carcinoma …

Cancer patients often experience weight loss caused by protein calorie malnutrition (PCM)
during the course of the disease or treatment. PCM is expressed as severe if the patient has …

Purpose Taste and smell disturbances in patients affected by cancer are very common, but
often under-recognized symptoms. If not addressed properly, they may impact nutritional …

Malnutrition is common in both adult and pediatric patients undergoing treatment for cancer.
Patients commonly attribute difficulties maintaining food intake to an altered taste developed …

Taste disorders are common among cancer patients undergoing chemotherapy, with a
prevalence ranging from 20% to 86%, persisting throughout treatment. This condition leads …

Background The sense of taste is very much essential to the overall health of an individual. It
is a necessary component to enjoy one's food, which in turn provides nutrition to an …

Acceptable palatability of an oral dosage form is crucial to patient compliance. Excipients
can be utilised within a formulation to mask the bitterness of a drug. One such category is the …

Background Metallic taste is a taste alteration frequently reported by cancer patients treated
with chemotherapy. Attention to this side effect of chemotherapy is limited. This review …